Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEVP of R&D & CTOCIK 0002040321
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Siegrist Jonathan PhilipEVP of R&D & CTO |  QDELQuidelOrtho CorpOption exercise | M | — 18.7K sh | Oct 19, 2026 traded Oct 15, 2026 | |
Siegrist Jonathan PhilipEVP of R&D & CTO |
| QDELQuidelOrtho Corp Option exercise |
| M |
| — 18.7K sh |
| Oct 19, 2026 traded Oct 15, 2026 |
| 20 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Tax withholding | F | $93K 6,695 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Grant or award | A | — 36.1K sh | Feb 3, 2026 traded Jan 30, 2026 |
| 9 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Grant or award | A | — 36.2K sh | Feb 3, 2026 traded Jan 30, 2026 |
| 17 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Grant or award | A | — 2,448 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 13 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Tax withholding | F | $28K 1,009 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 21 | Siegrist Jonathan PhilipEVP of R&D & CTO | QDELQuidelOrtho Corp Option exercise | M | — 2,448 sh | Feb 2, 2026 traded Jan 29, 2026 |